Bioavailability and Metabolism of Voriconazole in Relation to Its Modulation by the CYP2C19 Genetic Polymorphism
CompletedOBSERVATIONAL
Enrollment
24
Participants
Timeline
Start Date
July 31, 2005
Study Completion Date
July 31, 2006
Conditions
Healthy
Trial Locations (1)
69120
Clinical Research Unit, Department Internal Medicine VI, Heidelberg
All Listed Sponsors
lead
Heidelberg University
OTHER
NCT00175994 - Bioavailability and Metabolism of Voriconazole in Relation to Its Modulation by the CYP2C19 Genetic Polymorphism | Biotech Hunter | Biotech Hunter